• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION VERCISE? CARTESIA?; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION CORPORATION VERCISE? CARTESIA?; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number DB-2202-30
Medical Device Problem Codes High impedance (1291); Unexpected Therapeutic Results (1631)
Health Effect - Clinical Code Movement Disorder (4412)
Date of Event 03/10/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Initial reporter's phone number is (b)(6); reported here as phone number exceeded character limit for designated field.
 
Event or Problem Description
It was reported that the deep brain stimulation (dbs) patient experienced high impedances on contact eight of the right lead wherein causing inadequate stimulation and a return of dystonia symptoms.The patient underwent a revision procedure where the right lead was replaced.The patient was doing well postoperatively.
 
Event or Problem Description
It was reported that the deep brain stimulation (dbs) patient experienced high impedances on contact eight of the right lead wherein causing inadequate stimulation and a return of dystonia symptoms.The patient underwent a revision procedure where the right lead was replaced.The patient was doing well postoperatively.Additional information was received indicating the initially reported lead serial number was incorrect.The correct serial number was confirmed and updated.
 
Additional Manufacturer Narrative
Initial reporter's phone number is (b)(6); reported here as phone number exceeded character limit for designated field.The returned lead was analyzed, passed all tests performed, and exhibited normal device characteristics.A product labeling review identified that the device was used per the instructions for use (ifu) product label.It states failure or malfunction of any of the device components or battery including but not limited to lead or extension breakage, electrical shorts or open circuits and lead insulation breaches can cause loss of adequate stimulation and motor problems such as tremor, dystonia, or dyskinesias and may result in an explant or reimplantation and are known risks with the use of deep brain stimulation (dbs).
 
Event or Problem Description
It was reported that the deep brain stimulation (dbs) patient experienced high impedances on contact eight of the right lead wherein causing inadequate stimulation and a return of dystonia symptoms.The patient underwent a revision procedure where the right lead was replaced.The patient was doing well postoperatively.Additional information was received indicating the initially reported lead serial number was incorrect.The correct serial number was confirmed and updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE? CARTESIA?
Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key21769718
Report Number3006630150-2025-02124
Device Sequence Number18164484
Product Code NHL
UDI-Device Identifier08714729905271
UDI-Public(01)08714729905271(17)240723(10)7077619(21)7077619
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
P150031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date07/23/2024
Device Model NumberDB-2202-30
Device Catalogue NumberDB-2202-30
Device Lot Number7077619
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/14/2025
Supplement Date Received by Manufacturer04/17/2025
05/15/2025
Initial Report FDA Received Date04/03/2025
Supplement Report FDA Received Date05/14/2025
06/04/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/24/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-